QIAGEN NV
(NYSE : QGEN)

( )
QGEN PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
ABTAbbott Laboratories -2.88%76.640.8%$1071.33m
TMOThermo Fisher Scientific, Inc. -2.88%275.441.0%$865.21m
MDTMedtronic Plc -6.71%84.130.6%$856.00m
BDXBecton, Dickinson & Co. -1.91%225.381.1%$653.90m
ISRGIntuitive Surgical, Inc. -7.46%458.262.4%$652.39m
DHRDanaher Corp. -6.84%128.940.7%$641.66m
SYKStryker Corp. -13.17%144.571.3%$521.61m
BSXBoston Scientific Corp. -7.54%30.171.1%$467.64m
INOInovio Pharmaceuticals, Inc. 3.50%7.706.8%$449.25m
EWEdwards Lifesciences Corp. -8.34%172.891.2%$391.50m
DXCMDexCom, Inc. -5.37%254.818.2%$369.80m
BAXBaxter International, Inc. -3.25%78.551.8%$360.64m
ZBHZimmer Biomet Holdings, Inc. -11.20%89.761.7%$242.29m
IDXXIDEXX Laboratories, Inc. -4.78%230.663.8%$234.81m
ALGNAlign Technology, Inc. -9.63%157.206.4%$225.34m

Company Profile

QIAGEN NV is a holding company, which engages in the provision of sample and assay technology to transform biological samples into valuable molecular insights. It offers bioinformatics, molecular diagnostics, next-gen sequencing, and genomic services. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996 and is headquartered in Venlo, the Netherlands.